Related references
Note: Only part of the references are listed.Cancer statistics, 2023
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2023)
PD-L1 blockade liberates intrinsic antitumourigenic properties of glycolytic macrophages in hepatocellular carcinoma
Li-Gong Lu et al.
GUT (2022)
Hyperthermia promotes exosome secretion by regulating Rab7b while increasing drug sensitivity in adriamycin-resistant breast cancer
Di Xu et al.
INTERNATIONAL JOURNAL OF HYPERTHERMIA (2022)
Treatment landscape of triple-negative breast cancer - expanded options, evolving needs
Giampaolo Bianchini et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2022)
Event-free Survival with Pembrolizumab in Early Triple-Negative Breast Cancer
P. Schmid et al.
NEW ENGLAND JOURNAL OF MEDICINE (2022)
Colorectal Cancer-Derived Small Extracellular Vesicles Promote Tumor Immune Evasion by Upregulating PD-L1 Expression in Tumor-Associated Macrophages
Yuan Yin et al.
ADVANCED SCIENCE (2022)
Role of Biological Mediators of Tumor-Associated Macrophages in Breast Cancer Progression
Yan Li et al.
CURRENT MEDICINAL CHEMISTRY (2022)
Nivolumab plus chemotherapy or ipilimumab in gastro-oesophageal cancer
Kohei Shitara et al.
NATURE (2022)
Noncanonical PD-1/PD-L1 Axis in Relation to the Efficacy of Anti-PD Therapy
Yiru Long et al.
FRONTIERS IN IMMUNOLOGY (2022)
Tumor-associated macrophages: Potential target of natural compounds for management of breast cancer
RamaRao Malla et al.
LIFE SCIENCES (2022)
Small extracellular vesicles: from promoting pre-metastatic niche formation to therapeutic strategies in breast cancer
Xiaoxiao Chen et al.
CELL COMMUNICATION AND SIGNALING (2022)
PD-L1 status in breast cancer: Current view and perspectives
Semir Vranic et al.
SEMINARS IN CANCER BIOLOGY (2021)
Tumor-derived exosomal circPSMA1 facilitates the tumorigenesis, metastasis, and migration in triple-negative breast cancer (TNBC) through miR-637/Akt1/β-catenin (cyclin D1) axis
Su-jin Yang et al.
CELL DEATH & DISEASE (2021)
Metastatic heterogeneity of breast cancer: Molecular mechanism and potential therapeutic targets
Yiran Liang et al.
SEMINARS IN CANCER BIOLOGY (2020)
Evaluating the Polarization of Tumor-Associated Macrophages Into M1 and M2 Phenotypes in Human Cancer Tissue: Technicalities and Challenges in Routine Clinical Practice
Sharmilla Devi Jayasingam et al.
FRONTIERS IN ONCOLOGY (2020)
Pembrolizumab plus chemotherapy versus placebo plus chemotherapy for previously untreated locally recurrent inoperable or metastatic triple-negative breast cancer (KEYNOTE-355): a randomised, placebo-controlled, double-blind, phase 3 clinical trial
Javier Cortes et al.
LANCET (2020)
Isolation and characterization of exosomes for cancer research
Le Zhu et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2020)
Triple-negative breast cancer molecular subtyping and treatment progress
Li Yin et al.
BREAST CANCER RESEARCH (2020)
Exosome-Mediated Metastasis: Communication from a Distance
Inbal Wortzel et al.
DEVELOPMENTAL CELL (2019)
Extracellular miRNAs: From Biomarkers to Mediators of Physiology and Disease
Marcelo A. Mori et al.
CELL METABOLISM (2019)
Beyond 5 years: enduring risk of recurrence in oestrogen receptor-positive breast cancer
Juliet Richman et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2019)
The dual functional role of MicroRNA-18a (miR-18a) in cancer development
Kexin Shen et al.
CLINICAL AND TRANSLATIONAL MEDICINE (2019)
Single-Cell Map of Diverse Immune Phenotypes in the Breast Tumor Microenvironment
Elham Azizi et al.
CELL (2018)
Exosome-mediated miR-222 transferring: An insight into NF-κ-mediated breast cancer metastasis
Jiaji Ding et al.
EXPERIMENTAL CELL RESEARCH (2018)
Clinicopathological correlation of PD-L1 expression in primary and metastatic breast cancer and infiltrating immune cells
Ossama Tawfik et al.
HUMAN PATHOLOGY (2018)
Biogenesis and function of extracellular vesicles in cancer
Maarten P. Bebelman et al.
PHARMACOLOGY & THERAPEUTICS (2018)
Programmed Cell Death Ligand 1 (PD-L1) Signaling Regulates Macrophage Proliferation and Activation
Genevieve P. Hartley et al.
CANCER IMMUNOLOGY RESEARCH (2018)
Nivolumab Versus Docetaxel in Previously Treated Patients With Advanced Non-Small-Cell Lung Cancer: Two-Year Outcomes From Two Randomized, Open-Label, Phase III Trials (CheckMate 017 and CheckMate 057)
Leora Horn et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
PD-L1 on tumor cells is sufficient for immune evasion in immunogenic tumors and inhibits CD8 T cell cytotoxicity
Vikram R. Juneja et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2017)
Akt Signaling Pathway in Macrophage Activation and M1/M2 Polarization
Eleni Vergadi et al.
JOURNAL OF IMMUNOLOGY (2017)
MiR-106b and miR-93 regulate cell progression by suppression of PTEN via PI3K/Akt pathway in breast cancer
Nana Li et al.
CELL DEATH & DISEASE (2017)
miR-28-5p-IL-34-macrophage feedback loop modulates hepatocellular carcinoma metastasis
Shao-Lai Zhou et al.
HEPATOLOGY (2016)
Gut macrophage phenotype is dependent on the tumor microenvironment in colorectal cancer
Samuel E. Norton et al.
CLINICAL & TRANSLATIONAL IMMUNOLOGY (2016)
Tumour exosome integrins determine organotropic metastasis
Ayuko Hoshino et al.
NATURE (2015)
Cancer-Secreted miR-105 Destroys Vascular Endothelial Barriers to Promote Metastasis
Weiying Zhou et al.
CANCER CELL (2014)
Transcriptome-Based Network Analysis Reveals a Spectrum Model of Human Macrophage Activation
Jia Xue et al.
IMMUNITY (2014)
MPDL3280A (anti-PD-L1) treatment leads to clinical activity in metastatic bladder cancer
Thomas Powles et al.
NATURE (2014)
Microenvironmental regulation of tumor progression and metastasis
Daniela F. Quail et al.
NATURE MEDICINE (2013)
Microenvironmental Regulation of Epithelial-Mesenchymal Transitions in Cancer
Dingcheng Gao et al.
CANCER RESEARCH (2012)
Prognostic Significance of Tumor-Associated Macrophages in Solid Tumor: A Meta-Analysis of the Literature
Qiong-wen Zhang et al.
PLOS ONE (2012)
The blockade of immune checkpoints in cancer immunotherapy
Drew M. Pardoll
NATURE REVIEWS CANCER (2012)
Inhibition of tumor necrosis factor-induced cell death in MCF7 by a novel inhibitor of neutral sphingomyelinase
C Luberto et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)